Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Steven L. Basta
Age : 55
Public asset : 52,193 USD
Linked companies : VYNE Therapeutics Inc. - Viveve Medical, Inc.
Summary 
Steven L. Basta is a businessperson who has been the head of 8 different companies and is Chairman for Viveve Medical, Inc., Chairman of Viveve, Inc. (a subsidiary of Viveve Medical, Inc.) and Chief Executive Officer of Mahana Therapeutics, Inc. Mr. Basta is also on the board of DermBiont, Inc. and VYNE Therapeutics, Inc.

In the past he occupied the position of President & Chief Executive Officer of Gliatech, Inc., Chief Executive Officer at AlterG, Inc., Executive Director-Product Development at Orchestra Therapeutics, Inc., Chief Executive Officer of BioForm Medical, Inc., Director at Menlo Therapeutics, Inc., Chief Executive Officer at Merz Aesthetics, Inc., Chief Financial Officer & VP-Business Development at Creative Biomolecules, Inc. and Associate for Dillon, Read & Co., Inc.

Mr. Basta received an undergraduate degree from The Johns Hopkins University and an MBA from Kellogg School of Management.


Current positions of Steven L. Basta 
NameTitle Since
VYNE Therapeutics Inc.
(Pharmaceuticals)
Independent Director 2015
Viveve Medical, Inc.
(Advanced Medical Equipment & Technology)
Chairman 2019
Mahana Therapeutics, Inc. Chief Executive Officer -
Viveve, Inc. Chairman 2019
DermBiont, Inc. Director 2020


Holdings of Steven L. Basta 
NameEquities%Valuation
VYNE Therapeutics Inc. (VYNE)
(Pharmaceuticals)
134,1310.23%52,177 USD
Viveve Medical, Inc. (VIVE)
(Advanced Medical Equipment & Technology)
250.0002%16 USD


Steven L. Basta: Personal Network 
Most Read News 
07/27AMANCIO ORTEGA : Inditex founder Ortega buys 5% in Enagas's renewable, hydrogen unit
RE
07/29MARK ZUCKERBERG : Company's pandemic-era forecast was too rosy
RE
07/26MARK ZUCKERBERG : As Zuckerberg bets on TikTok-style videos, Meta heads for first-ever revenue drop
RE
07/29CATHIE WOOD : Wood's ARK fund on track for first monthly gain since Oct as risky stocks rally
RE
08/06ELON MUSK : Musk says Twitter deal should go ahead if it provides proof of real accounts
RE
08/04JACK DORSEY : Dorsey-led Block posts loss for second quarter
RE
08/02ELON MUSK : Twitter queries banks on Musk's attempts to undermine $44 billion deal
RE
07/28JACK MA : Jack Ma plans to give up control of Ant Group - WSJ
RE
08/09ELON MUSK : Elon Musk sells 7.92 million Tesla shares worth $6.9 billion - SEC filing
RE
08/01DAVID EINHORN : Einhorn's Greenlight takes stake in Twitter - letter
RE
More news


© 2022 People and Ownership :   
Steven L. Basta : Connections